0000000000471506

AUTHOR

Carlo Di Gregorio

showing 7 related works from this author

Lower eyelid reconstruction by multiple subcutaneous pedicle flaps: a new method.

1992

Abstract In this paper we present an original technique for the reconstruction of the full thickness of the lower eyelid after excision of neoplasms. The method is based on the mobilisation of multiple pedicle subcutaneous flaps outlined in the same eyelid and supported by a chondro-mucosal graft. This technique is used for central and off-central losses which involve the outer rim or up to 75% of the width of the whole eyelid. This method is an alternative to the Hughes (1945), Mustarde´(1981), Tenzel and Stewart (1978) and McGregor (1973) techniques which we have previously used for this type of reconstructive The follow-up is satisfactory in terms of the oncological, functional and aesth…

Pedicle flapmedicine.medical_specialtybusiness.industryEyelidsAnatomyEyelid Neoplasmseye diseasesSurgical FlapsSurgeryNasal Mucosamedicine.anatomical_structureCartilageOtorhinolaryngologyEyelid surgeryConnective TissuemedicineHumansSurgeryFull thicknesssense organsEyelidbusinessSubcutaneous pedicleBritish journal of plastic surgery
researchProduct

Hyaluronic acid-based two-stage medical therapy to unfold the aged face: The centrifugal approach

2020

Background: Facial aging is a multifactorial process characterized by structural changes to the dermis and ligaments, lipoatrophy in the fat pads and hypodermis, remodeling of the bony skeleton, change in muscle tonicity and tissue descent. Aims: The purpose of this study is to evaluate the efficacy of a hyaluronic acid-based treatment for the aging face that addresses all its causes in a caudal to cranial and medial to lateral direction: the centrifugal technique. Methods: Between March 2015 and January 2018, 187 patients were treated with a high G’ hyaluronic acid in two sessions, one/two weeks apart, to improve signs of facial aging, starting from the lower centrofacial area and progress…

Facial rejuvenationSettore MED/19 - Chirurgia PlasticaDentistryCosmetic TechniquesDermatology030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDermisfacial rejuvenationHyaluronic acidhyaluronic acidHumansRejuvenationMedicineStage (cooking)LipoatrophyAgedmidface agingbusiness.industrymedicine.diseaseSkeleton (computer programming)Nasolabial foldSkin AgingTreatment Outcomemedicine.anatomical_structurechemistryPatient Satisfaction030220 oncology & carcinogenesisnasolabial foldbusinessMedical therapy
researchProduct

Nonsurgical treatment of earlobe aging in Mowlavi stages I and II earlobe ptosis with Hyaluronic acid fillers.

2018

Background: Earlobe deflation caused by fat atrophy is normally treated with lipofilling, mostly in the context of facelift surgery. In this report, we aim at reporting on Hyaluronic Acid injections to treat earlobe deflation. Materials and Methods: 16 Mowlavi Grade I and II patients were treated with HA injections, followed by molding to shape the lobule. Results: Effective correction, lasting 14 months on average, is achieved. Five patients needed a touch-up procedure after 4-6 months to improve the result. Conclusions: Earlobe augmentation with HA is an ideal option for correction of earlobe atrophy in cases of Mowlavi Grades I and II ptosis. Long-lasting (about 14 months) correction is …

Malemedicine.medical_specialtyTime FactorsInjections IntradermalSettore MED/19 - Chirurgia PlasticaFacelift surgeryContext (language use)DermatologyCosmetic Techniques030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAtrophyPtosisearlobeDermal FillersHyaluronic acidmedicineHumansRejuvenationHyaluronic AcidEarlobebusiness.industryagingMiddle Agedmedicine.diseaseNonsurgical treatmentSurgerySkin Agingmedicine.anatomical_structureTreatment Outcomechemistry030220 oncology & carcinogenesisFemaleFat atrophymedicine.symptombusinessEar AuricleJournal of cosmetic dermatology
researchProduct

Cheek Volumization and the Nasolabial Fold.

2018

Sir: We have read the article by Mowlds and Lambros1 with great interest and enthusiasm. The findings of their study show that the nasolabial fold does not improve after cheek injection. By analyzing three-dimensional images of the face before and immediately after cheek injection of high- G′ hyaluronic acid, they demonstrate that the perceived nasolabial fold improvement, reported after cheek injections,2,3 is attributable to overall improvement in facial appearance rather than to actual nasolabial fold improvement. As a consequence, it might be ruled out that the nasolabial fold is a consequence of cheek deflating and it is likely attributable predominantly to change in the corner of the …

MaleNasolabial FoldInjections SubcutaneousSettore MED/19 - Chirurgia PlasticaFacial MusclesAdipose tissueCosmetic Techniques030230 surgery030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineImaging Three-DimensionalDermal FillersmedicineImage Processing Computer-AssistedPhotographyHumansHyaluronic AcidInjections subcutaneousOrthodonticsbusiness.industryAnatomyCheekNasolabial foldFacial MuscleFacial Expressionstomatognathic diseasesFacial musclesmedicine.anatomical_structureCheekAdipose Tissue030220 oncology & carcinogenesisSurgeryFemalebusinessPlastic and reconstructive surgery
researchProduct

Therapeutic use of hyaluronic acid fillers in the treatment of corticosteroid-induced skin and subcutaneous atrophy

2016

Corticosteroid injection–related tissue atrophy might cause permanent skin and soft tissue deformities1 due to several factors, most importantly fibroblast inhibition and decreased Type I collagen synthesis. Correction of these deformities is challenging and is mostly based on volume replacement with lipofilling or other methods. Clinical observations and research have shown that injection of stabilized hyaluronic acid (HA) induces collagen synthesis, partially restoring dermal matrix components, and eventually producing a permanent effect.2–5 Based on these data, we hypothesize that HA injections might successfully treat atrophic tissue changes caused by corticosteroid injection. We descri…

medicine.medical_specialtyDermal FillerEstheticsLipodystrophymedicine.drug_classInjections SubcutaneousSettore MED/19 - Chirurgia PlasticaBiocompatible MaterialsDermatologyCosmetic TechniquesAdrenal Cortex HormoneInjections SubcutaneouDermal Fillers030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAtrophyIn vivoAdrenal Cortex HormonesDermal FillersHyaluronic acidmedicineHumansButtocksHyaluronic AcidBiocompatible MaterialCosmetic Techniquebusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDermatologymedicine.anatomical_structureCosmetic Techniqueschemistry030220 oncology & carcinogenesisCorticosteroidButtocksSurgeryFemaleLipodystrophyAtrophybusinessEstheticHuman
researchProduct

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck

1997

BACKGROUND The combination of vinorelbine (VNR), cisplatin (CDDP), and 5-fluorouracil (5-FU) has previously been shown to be active in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCHNC). This multicenter Phase II study was carried out with the aim of evaluating the effectiveness of this combination in patients with previously untreated, unresectable locally advanced SCHNC. METHODS Sixty patients with previously untreated, unresectable SCHNC were treated with CDDP 80 mg/m2 on Days 1, 5-FU 600 mg/m2 as a 4-hour infusion on Days 2-5, and VNR 25 mg/m2 iv bolus on Days 2 and 8. There were 15 patients with laryngeal carcinoma, 19 patients with oropharyngeal carcinoma…

MaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentPhases of clinical researchVinblastineVinorelbineGastroenterologyDisease-Free SurvivalInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansAgedChemotherapybusiness.industryInduction chemotherapyVinorelbineMiddle Agedmedicine.diseaseSurgeryRegimenOncologyEpidermoid carcinomaChemotherapy AdjuvantHead and Neck NeoplasmsFluorouracilCarcinoma Squamous CellFemaleRadiotherapy AdjuvantFluorouracilCisplatinbusinessmedicine.drugCancer
researchProduct

Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report

2008

Abstract Introduction Thyroglossal duct carcinoma is a very rare finding and its presentation is similar to that of a benign cyst, which is a relatively common developmental abnormality that may manifest as a midline, neck mass. In general the diagnosis of thyroglossal duct carcinoma is based on the pathologic examination of the mass, but needle aspiration cytology, ultrasound and computed tomography play a role in the differential diagnosis of malignancy. Case presentation A further case of thyroglossal duct carcinoma and concurrent thyroid carcinoma with locoregional lymph node metastases affecting a 40-year-old woman followed up for 4 years is presented and discussed. Conclusion Sistrunk…

Medicine(all)Pathologymedicine.medical_specialtybusiness.industryThyroglossal ductlcsh:RNeck massThyroidlcsh:MedicineCase ReportGeneral Medicinemedicine.diseaseMalignancyThyroid carcinomamedicine.anatomical_structuremedicineCarcinomaCystDifferential diagnosismedicine.symptombusinessJournal of Medical Case Reports
researchProduct